News

The bleeding control kit market is on a steady growth trajectory, driven by increasing demand for emergency trauma care solutions worldwide. According to recent estimates, the market was valued at USD ...
Thrombosis, Hemostasis, and Cancer Collaborative (UVMCC ... It specializes in the treatment of all inherited and acquired bleeding disorders, including Hemophilia, von Willebrand Disease, platelet ...
RESEARCHERS AT MASS GENERAL HOSPITAL NOW BELIEVE YOU CAN USE YOUR SENSE OF SMELL AS SERVE AS AN EARLY WARNING SIGN FOR ALZHEIMER’S AND OTHER MEMORY DISORDERS. WE GOT AN INSIDE LOOK AT THE NEW ...
The most expensive drug category for nonfederal hospitals in 2024 were antineoplastic targeted agents, according to a study published in the American Journal of Health-System Pharmacy.  The report, ...
United States is projected to witness a CAGR of 8.1% from 2025 to 2035, indicating strong market growth. United Kingdom is expected to grow at a CAGR of 7.7%, showcasing steady expansion. European ...
On today’s Palestine Post, we speak with Harvard law student and KPFA correspondent Ariel Boone as well as Dr Lara Jirmanus, a Palestinian-Lebanese-American physician and a clinical instructor at ...
May 5, 2025 — The fact that left-handedness resp. mixed-handedness are strikingly common in patients with certain neurological disorders such as autism spectrum disorders is a frequently ...
The HEMASHIELD grafts are the most used, most studied vascular products available in the market today. More than 2 million HEMASHIELD grafts have been implanted worldwide, demonstrating clinical ...
There is interest in using quercetin for a number of other purposes, but there isn't enough reliable information to say whether it might be helpful. Pregnancy and breast-feeding: There isn't ...
The optimal choice for thoracic vascular reconstruction, collagen-coated INTERGARD Woven vascular grafts utilize low-twist, highly filamentous yarns, giving them excellent strength and suturing ...
Purpose The pharmacology, pharmacokinetics, efficacy, and safety of apixaban are reviewed. Summary Apixaban is an oral, direct, selective factor Xa inhibitor with a rapid onset of action. It has a ...